On the other hand, TPD54 downregulation increases PDH E1α protein degradation and leads to decreased PDH enzyme activity, which reduces mitochondrial oxygen consumption and reactive oxygen species (ROS) production, thus contributing to the resistance of breast cancer cells to metformin treatment. Here, DHTKD1 is linked to breast carcinoma.